Quinn Opportunity Partners LLC Vigil Neuroscience, Inc. Put Options Transaction History
Quinn Opportunity Partners LLC
- $1.08 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VIGL
# of Institutions
61Shares Held
29.1MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$47 Million3.04% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.9 Million51.65% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$32.3 Million0.31% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$15.8 Million0.2% of portfolio
-
683 Capital Management, LLC New York, NY1.74MShares$14 Million0.25% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $228M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...